6 news items
Evaxion Receives Nasdaq Notification
EVAX
10 May 24
parties including for conduct of clinical testing and product manufacture; our inability to enter into partnerships; government regulation; protection
Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01
EVAX
17 Apr 24
testing and product manufacture; our inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
EVAX
2 Apr 24
manufacture; our inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee matters and managing
Evaxion Announces Business Update and Full Year 2023 Financial Results
EVAX
27 Mar 24
inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee matters and managing growth
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
EVAX
19 Mar 24
; government regulation; protection of our intellectual property rights; employee matters and managing growth; our ADSs and ordinary shares, the impact
kpnlqji ayyq4j4ucgibfm5y1f6uhzw0kyk
EVAX
29 Feb 24
manufacture; our inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee matters and managing
- Prev
- 1
- Next